GSK Prodded Toward Mediation In Avandia MDL
Less than a week after GlaxoSmithKline PLC paid $3 billion to settle U.S. government probes into, among other practices, its marketing of Avandia, a Pennsylvania federal judge on Monday pushed the...To view the full article, register now.
Already a subscriber? Click here to view full article